CTO

Citius Oncology, Inc.

CTORXNAS

Citius Oncology, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Leonard L. Mazur, with a market cap of $58.3M.

Market Cap$58.3M
CEOLeonard L. Mazur
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 13, 2026 · in a monthQ2 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
CTO

Citius Oncology, Inc. FAQ

Common questions about Citius Oncology, Inc.

Citius Oncology, Inc. is scheduled to report earnings for Q2 2026 on May 13, 2026. Analysts estimate revenue of $7.0M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.